EPCAM and neoplasm: We designed an antibody cocktail of lineage markers (CD24, CD31, CD45.2, CD49f, EpCAM, TER-119 and LYVE-1) to exclude non-fibroblast cells from the single cell suspension of tumours analysed by flow cytometry (FCM) (Fig. 1a and Table 2).